Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling

Ji‐Hee Kim(Howard Hughes Medical Institute), Seungkirl Ahn(Howard Hughes Medical Institute), Xiu-Rong Ren(Howard Hughes Medical Institute), Erin J. Whalen(Howard Hughes Medical Institute), Éric Reiter(Howard Hughes Medical Institute), Huijun Wei(Howard Hughes Medical Institute), Robert J. Lefkowitz(Howard Hughes Medical Institute)
Proceedings of the National Academy of Sciences
January 25, 2005
Cited by 343Open Access
Full Text

Abstract

beta-arrestins bind to G protein-coupled receptor kinase (GRK)-phosphorylated seven transmembrane receptors, desensitizing their activation of G proteins, while concurrently mediating receptor endocytosis, and some aspects of receptor signaling. We have used RNA interference to assess the roles of the four widely expressed isoforms of GRKs (GRK 2, 3, 5, and 6) in regulating beta-arrestin-mediated signaling to the mitogen-activated protein kinase, extracellular signal-regulated kinase (ERK) 1/2 by the angiotensin II type 1A receptor. Angiotensin II-stimulated receptor phosphorylation, beta-arrestin recruitment, and receptor endocytosis are all mediated primarily by GRK2/3. In contrast, inhibiting GRK 5 or 6 expression abolishes beta-arrestin-mediated ERK activation, whereas lowering GRK 2 or 3 leads to an increase in this signaling. Consistent with these findings, beta-arrestin-mediated ERK activation is enhanced by overexpression of GRK 5 and 6, and reciprocally diminished by GRK 2 and 3. These findings indicate distinct functional capabilities of beta-arrestins bound to receptors phosphorylated by different classes of GRKs.


Related Papers

No related papers found

Powered by citation graph analysis